MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$28,622K
Therapy
$854K
Procedures
$371K
Loss from operations
-$16,224K
Total other expense,
net
-$12,398K
Net patient service
revenue
$1,225K
Gain on exercise of
warrants
$5,369K
Interest income
$12K
Total operating
expenses
$17,449K
Loss on convertible
note conversions
-$6,201K
Change in fair value of
warrant liabilities
$4,926K
Change in fair value of
convertible notes payable
$3,939K
Loss on
consideration shares and...
-$1,277K
Loss on issuance of
registered direct offering
-$730K
Interest expense
$671K
Loss from equity
method investments
-$35K
Selling, general and
administrative
$13,061K
Research and development
$3,777K
Cost of patient
services
$505K
Depreciation and
amortization
$70K
Settlement expense
(income)
$36K
Back
Back
Income Statement
source: myfinsight.com
NRX Pharmaceuticals, Inc. (NRXPW)
NRX Pharmaceuticals, Inc. (NRXPW)